%0 Generic
%A Munoz-Barrera, L.
%A Perez-Sanchez, C.
%A Contreras, A. Escudero
%A Aguirre-Zamorano, M. A.
%A Gutierrez, J. Calvo
%A Castro, R. Ortega
%A Romero-Gomez, M.
%A Sanchez-Pareja, I.
%A Abalos-Aguilera, M. C.
%A Puerto, N. Barbarroja
%A Venegas, J. J. Perez
%A Ruiz-Montesinos, D.
%A Rodriguez-Escalera, C.
%A Romero-Barco, C. M.
%A Mena-Vazquez, N.
%A Fernandez-Nebro, A.
%A Uceda, J.
%A Marenco, J. L.
%A Estevez, E. Collantes
%A Lopez-Pedreraon, C.
%T THE ANALYSIS OF THE INFLAMMATORY PROTEOME IN RHEUMATOID ARTHRITIS IDENTIFIES COMMON SIGNATURES ASSOCIATED WITH THE CLINICAL RESPONSE TO DMARDS AND TNFI THERAPIES
%D 2022
%@ 0003-4967
%U http://hdl.handle.net/10668/20117
%X Background: The clinical outcome of the most common therapeutic options of rheumatoid arthritis (RA) patients, such as conventional disease-modifying antirheumatic drugs (DMARDs) and TNF inhibitors (TNFi) is still unpredictable, since a high percentage of patients do not response to the therapy. Innovative analyses combining high-throughput technologies and thorough clinical assessments are needed to gain insight about the management of this prevalent autoimmune disorder.
%~